Overall: As with every ASH, we are able to witness up close and personal the exciting advances in science and medicine – the research moving us more and more towards precision medicine, the current...
Post-ASH: Reflections
read more
Gail McCray
Following three months of intense back pain, Gail McCray was diagnosed with multiple myeloma in 2008. After ASCT, she went through 7 years of remission before having a relapse but found a regimen that put her into sCR for a second time. Gail is a Community Health Educator working to close the gap between health care providers and community/individual health and to get patients to be more involved with their health. She is focused on translating research into practice and on the end-user of bioresearch. Gail has been a co-leader of the Southside Atlanta MM Support Group for 12 years. This is Gail’s second time attending the ASH conference. New therapies, upcoming clinical trials, genetics, genomics, precision medicine, and research determining disparities in the incidence of myeloma in African Americans and other ethnic groups are Gail’s topics of interest.
Follow Gail on Twitter: @IMFgailMYELOMA
Support Group Website: Southside Atlanta MM Support Group
Pre-conference Jitters
Excitement and a bit of trepidation are the emotions I would attribute to the eve of my third opportunity to attend the 64th American Society of Hematology Annual Meeting. I will attend virtually...